Retinopathy of incontinentia pigmenti: A case report with thirteen years follow-up

Ophthalmic Genetics

Volumn 24, Issue 4, 2003, Pages 247-252

  Cates, Carolyn A ^a   Dandekar, Samantha S ^b   Flanagan, Declan W ^a   Moore, Anthony T ^b,c  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b MOORFIELDS EYE HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Incontinentia pigmenti; Proliferative retinopathy; X linked

Indexed keywords

ADOLESCENT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DELETION MUTANT; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC IMAGING; DISEASE COURSE; EXON; FEMALE; FLUORESCENCE ANGIOGRAPHY; GENE IDENTIFICATION; HUMAN; INCONTINENTIA PIGMENTI; MUTATIONAL ANALYSIS; MUTATOR GENE; PRIORITY JOURNAL;

CHILD, PRESCHOOL; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; FUNDUS OCULI; HUMANS; INCONTINENTIA PIGMENTI; RETINAL DISEASES; VISUAL ACUITY;

EID: 0344155288     PISSN: 13816810     EISSN: None     Source Type: Journal    
DOI: 10.1076/opge.24.4.247.17237     Document Type: Article

References (18)

1. McKusick VA. Mendelian inheritance in man. Baltimore: John Hopkins University Press, 1992.
2. Carney RG. Incontinentia pigmenti - a world statistical analysis. Arch Dermatol. 1976;112:535-542.
3. Holmstrom G, Thoren K. Ocular manifestations of incontinentia pigmenti. Acta Ophthalmol Scand. 2000;78(3):348-353.
4. McCrary JA, Lawton Smith J. Conjunctival and retinal incontinentia pigmenti. Arch Ophthalmol 1968;79:417-422.
5. Ferreira RC, Ferreira LC, Forstot L, King R. Corneal abnormalities associated with incontinentia pigmenti. Am J Ophthalmol. 1997; 123:549-551.
6. The International Incontinentia Pigmenti (IP) Consortium. Genomic rearrangement in NEMO impairs NF-kappa B activation and is a cause of incontinentia pigmenti. Nature. 2000;405:466-472.
7. Aradhya S, Woffendin H, Jakins T, Bardaro T, Esposito T, Smahi A, Shaw C, Levy M, Munnich A, D'Urso M, Lewis RA, Kenwrick S, Nelson DA. A recurrent deletion in the ubiquitously expressed NEMO (IKK-gamma) gene accounts for the vast majority of incontinentia pigmenti mutations. Hum Mol Genet. 2001;1:2171-2179.
8. The International Incontinentia Pigmenti (IP) Consortium. Survival of male patients with incontinentia pigmenti carrying a lethal mutation can be explained by somatic mosaicism or Klinefelter syndrome. Am J Hum Genet. 2001;69:1210-1217.
9. Mansour S, Woffendin H, Mitton S, Jeffery I, Kenwrick S, Murday VA. Incontinentia pigmenti in a surviving male is accompanied by hypohidrotic ectodermal dysplasia and recurrent infection. Am J Med Genet. 2001;99:172-177.
10. Makris C, Godfrey VL, Krahn-Senftleben G, Takahashi T, Roberts JL, Schwartz T, Feng L, Johnson RS, Karin M. Female mice heterozygous for IKK-gamma/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti. Mol Cell. 2000;5:969-979.
11. Goldberg MF. The blinding mechanisms of incontinentia pigmenti. Ophthalmic Genet. 1994; 15:69-76.
12. Findlay GH. On the pathogenesis of incontinentia pigmenti, with observations on an associated eye disturbance resembling retrolental fibroplasia. Br J Dermatol. 1952;64: 141-146.
13. Goldberg MF, Custis PH. Retinal and other manifestations of incontinentia pigmenti (Bloch-Sulzberger syndrome). Ophthalmology. 1993;100:1645-1654.
14. Nishimura M, Oka Y, Takagi I, Yamana T, Kitano A. The clinical features and treatment of the retinopathy of Bloch-Sulzberger syndrome (incontinentia pigmenti). Jpn J Ophthalmol. 1980;24:310-319.
15. Watzke RC, Stevens TS, Carney RG. Retinal vascular changes of incontinentia pigmenti. Arch Ophthalmol. 1976;94:743-746.
16. Rahi J, Hungerford J. Early diagnosis of the retinopathy of incontinentia pigmenti: successful treatment by cryotherapy. Br J Ophthalmol. 1990;74:377-379.
17. Yu YS, Cho BJ. Cryotherapy for retinopathy of incontinentia pigmenti. Korean J Ophthalmol. 1991;5:47-50.
18. Wald KJ, Mehta MC, Katsumi O, Sabates NR, Hirose T. Retinal detachments in incontinentia pigmenti. Arch Ophthalmol. 1993;111:614-617.